Movement Alert|GeneDx Holdings Falls 5.53% in Pre-Market Trading, Shares Extend Losses on Cautious Post-Earnings Guidance

Market Focus11-13

On November 13, GeneDx Holdings fell 5.53% in Pre-Market Trading, trading at $48.9 per share, with turnover of $3.5349 million.

The clearest catalyst was continued market digestion of cautious guidance issued with the latest quarterly report, despite earnings and revenue both slightly exceeding consensus.

GeneDx Holdings reported adjusted EPS of $0.28 for the September quarter, above the $0.07 consensus, on revenue of $123.1 million versus expectations of $122.9 million. However, Q4 revenue guidance of $135 million was below the $142.6 million consensus, while full-year revenue guidance was maintained at $475 million to $490 million rather than raised. Analyst support remained in place, with Piper Sandler maintaining a Buy and $95 target, but BTIG cut its target to $85 from $90 and Jefferies lowered its target to $80 from $100, reinforcing a more cautious view on the near-term growth pace.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment